Daniel Frendl, MD
Urology · Scottsdale, AZNPI 1003290867
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $9,000 of the $14,827 with a category attached, or 60.7%. Boston Scientific accounts for 72.2% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $10,901, more than ten times the $496 reported in 2022.
Across 46 payments — averaging $322.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$11K
- BK Medical Holding Company Inc.$2K
- EDAP Technomed Inc$812
- Histosonics, Inc.$533
- Blue Earth Diagnostics$529
- Angiodynamics, Inc.$422
- plus $158 from 1 others
What the payments were for
- Consulting fees$9,00061%
- Speaking & faculty fees$1,66311%
- Travel & lodging$1,48510%
- Food & beverage$2,68018%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 20 | $10,710 |
| BK Medical Holding Company Inc. | 2 | $1,663 |
| EDAP Technomed Inc | 8 | $812 |
| Histosonics, Inc. | 2 | $533 |
| Blue Earth Diagnostics | 6 | $529 |
| Angiodynamics, Inc. | 7 | $422 |
| I/o Urology Corp. | 1 | $158 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL ONCOLOGY$9,000
- bk3000, bk3500 & bk5000 Ultrasound System$1,663
- POSLUMA$382
- FOCAL ONE$296
- CarePath$158
- Nanoknife$153
- Tria Firm$143
- GENERAL - THERAPIES$106
How this compares
$14,827 in reported general payments places this provider in the 85th percentile of 269 urology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 16 | $223 |
Paid to pharmacies, not to this prescriber.
Other urology in Scottsdale
- Michael ZellScottsdale$64K
- Thayne LarsonScottsdale$48K
- Jackson CaboScottsdale$36K
- Mark TysonScottsdale$34K
- Anojan NavaratnamScottsdale$30K
- Bernard GburekScottsdale$27K
- Matthew SteinwayScottsdale$23K
- Kelli GrossScottsdale$21K
- James DaitchScottsdale$16K
- Mitchell HumphreysPhoenix$358K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.